<p>The present invention relates to a stable oral pharmaceutical composition comprising atorvastatin or its pharmaceutically acceptable salt and suitable alkali metal salt additives in an amount of more than 5 % w/w so as to prevent degradation of the atorvastatin or its pharmaceutically acceptable salt.</p>
